New drug combinations could improve therapies for breast cancer, other aggressive cancers

by Angela Yeager,Oregon Health & Science UniversityQuantification of CD8+T cells by multispectral flow cytometry in an ex vivo co-culture assay. Credit:Cell Reports Medicine&nbsp

Updated on: September 10,2024

New drug combinations could improve therapies for breast cancer, other aggressive cancers

by Angela Yeager,Oregon Health & Science UniversityQuantification of CD8+T cells by multispectral flow cytometry in an ex vivo co-culture assay. Credit:Cell Reports Medicine&nbsp

Updated on:September 10,2024

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on: April 22,2024

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on:April 22,2024

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on: January 04,2024

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on:January 04,2024

Blood-based biomarker may redefine future treatment for advanced melanoma

byElsevierCirculating tumor DNA (ctDNA) correlates with radiology disease assessment and patient outcome. For patient A, biomarkers in their blood decreased over time and the radiology showed th

Updated on: January 05,2024

Blood-based biomarker may redefine future treatment for advanced melanoma

byElsevierCirculating tumor DNA (ctDNA) correlates with radiology disease assessment and patient outcome. For patient A, biomarkers in their blood decreased over time and the radiology showed th

Updated on:January 05,2024

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t

Updated on: December 18,2023

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t

Updated on:December 18,2023

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on: July 17,2024

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on:July 17,2024

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim

Updated on: December 22,2023

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim

Updated on:December 22,2023

As another obesity-fighting drug takes center stage, a nutrition expert discusses weight loss

by Mandy Conrad,The ConversationCredit: Unsplash/CC0 Public DomainIf the buzz surrounding a medication could elevate it to celebrity status, thenZepboundis reaching Taylor Swift rank

Updated on: March 26,2024

As another obesity-fighting drug takes center stage, a nutrition expert discusses weight loss

by Mandy Conrad,The ConversationCredit: Unsplash/CC0 Public DomainIf the buzz surrounding a medication could elevate it to celebrity status, thenZepboundis reaching Taylor Swift rank

Updated on:March 26,2024

Obstacles for breast cancer prevention in high-risk Black women

by Misti Crane,The Ohio State UniversityCredit: Unsplash/CC0 Public DomainBlack women at high risk of breast cancer face a variety of obstacles that may keep them from care that could prevent ca

Updated on: December 22,2023

Obstacles for breast cancer prevention in high-risk Black women

by Misti Crane,The Ohio State UniversityCredit: Unsplash/CC0 Public DomainBlack women at high risk of breast cancer face a variety of obstacles that may keep them from care that could prevent ca

Updated on:December 22,2023

Researchers find breast cancer protein that could predict chemotherapy sensitivity

by Hunter Medical Research InstituteThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Center for

Updated on: February 20,2024

Researchers find breast cancer protein that could predict chemotherapy sensitivity

by Hunter Medical Research InstituteThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Center for

Updated on:February 20,2024

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on: June 01,2024

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on:June 01,2024

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed

Updated on: December 22,2023

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed

Updated on:December 22,2023